134 related articles for article (PubMed ID: 16632234)
1. Glycemic control with regular versus lispro insulin sliding scales in hospitalized Type 2 diabetics.
Alfonso A; Koops MK; Mong DP; Vigersky RA
J Diabetes Complications; 2006; 20(3):153-7. PubMed ID: 16632234
[TBL] [Abstract][Full Text] [Related]
2. Lispro insulin treatment in comparison with regular human insulin in type 2 diabetic patients living in nursing homes.
Velussi M
Diabetes Nutr Metab; 2002 Apr; 15(2):96-100. PubMed ID: 12059098
[TBL] [Abstract][Full Text] [Related]
3. Randomized, open-label, parallel-group evaluations of basal-bolus therapy versus insulin lispro premixed therapy in patients with type 2 diabetes mellitus failing to achieve control with starter insulin treatment and continuing oral antihyperglycemic drugs: a noninferiority intensification substudy of the DURABLE trial.
Miser WF; Arakaki R; Jiang H; Scism-Bacon J; Anderson PW; Fahrbach JL
Clin Ther; 2010 May; 32(5):896-908. PubMed ID: 20685497
[TBL] [Abstract][Full Text] [Related]
4. Mealtime treatment with insulin analog improves postprandial hyperglycemia and hypoglycemia in patients with non-insulin-dependent diabetes mellitus. Multicenter Insulin Lispro Study Group.
Anderson JH; Brunelle RL; Keohane P; Koivisto VA; Trautmann ME; Vignati L; DiMarchi R
Arch Intern Med; 1997 Jun; 157(11):1249-55. PubMed ID: 9183237
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of insulin lispro in combination with NPH human insulin twice per day in patients with insulin-dependent or non-insulin-dependent diabetes mellitus. Multicenter Insulin Lispro Study Group.
Vignati L; Anderson JH; Iversen PW
Clin Ther; 1997; 19(6):1408-21. PubMed ID: 9444449
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of short term continuous subcutaneous insulin lispro versus continuous intravenous regular insulin in poorly controlled, hospitalized, type 2 diabetic patients.
Boullu-Sanchis S; Ortega F; Chabrier G; Busch MS; Uhl C; Pinget M; Jeandidier N
Diabetes Metab; 2006 Sep; 32(4):350-7. PubMed ID: 16977263
[TBL] [Abstract][Full Text] [Related]
7. Insulin lispro therapy in pregnancies complicated by type 1 diabetes mellitus.
Persson B; Swahn ML; Hjertberg R; Hanson U; Nord E; Nordlander E; Hansson LO
Diabetes Res Clin Pract; 2002 Nov; 58(2):115-21. PubMed ID: 12213353
[TBL] [Abstract][Full Text] [Related]
8. Lispro is superior to regular insulin in transient intensive insulin therapy in type 2 diabetes.
Murase Y; Yagi K; Sugihara M; Chujo D; Otsuji M; Muramoto H; Mabuchi H
Intern Med; 2004 Sep; 43(9):779-86. PubMed ID: 15497510
[TBL] [Abstract][Full Text] [Related]
9. Switch to multiple daily injections with insulin glargine and insulin lispro from continuous subcutaneous insulin infusion with insulin lispro: a randomized, open-label study using a continuous glucose monitoring system.
Bode BW; Steed RD; Schleusener DS; Strange P
Endocr Pract; 2005; 11(3):157-64. PubMed ID: 16239201
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes with insulin lispro compared with human regular insulin: a meta-analysis.
Davey P; Grainger D; MacMillan J; Rajan N; Aristides M; Gliksman M
Clin Ther; 1997; 19(4):656-74. PubMed ID: 9377611
[TBL] [Abstract][Full Text] [Related]
11. Prandial insulin substitution with insulin lispro or insulin lispro mid mixture vs. basal therapy with insulin glargine: a randomized controlled trial in patients with type 2 diabetes beginning insulin therapy.
Kazda C; Hülstrunk H; Helsberg K; Langer F; Forst T; Hanefeld M
J Diabetes Complications; 2006; 20(3):145-52. PubMed ID: 16632233
[TBL] [Abstract][Full Text] [Related]
12. Glycemic control with Humalog Mix25 in type 2 diabetes inadequately controlled with glyburide.
Roach ; Koledova E; Metcalfe S; Hultman C; Milicevic Z;
Clin Ther; 2001 Oct; 23(10):1732-44. PubMed ID: 11726007
[TBL] [Abstract][Full Text] [Related]
13. The effect of insulin lispro on glycemic control in a large patient cohort.
Lind M; Fahlén M; Happich M; Odén A; Eliasson B
Diabetes Technol Ther; 2009 Jan; 11(1):51-6. PubMed ID: 19132856
[TBL] [Abstract][Full Text] [Related]
14. Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial.
Bretzel RG; Nuber U; Landgraf W; Owens DR; Bradley C; Linn T
Lancet; 2008 Mar; 371(9618):1073-84. PubMed ID: 18374840
[TBL] [Abstract][Full Text] [Related]
15. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment: a randomized study. The Study Group for the Development of Pump Therapy in Diabetes.
Hanaire-Broutin H; Melki V; Bessières-Lacombe S; Tauber JP
Diabetes Care; 2000 Sep; 23(9):1232-5. PubMed ID: 10977011
[TBL] [Abstract][Full Text] [Related]
16. Management of diabetes mellitus in hospitalized patients: efficiency and effectiveness of sliding-scale insulin therapy.
Golightly LK; Jones MA; Hamamura DH; Stolpman NM; McDermott MT
Pharmacotherapy; 2006 Oct; 26(10):1421-32. PubMed ID: 16999652
[TBL] [Abstract][Full Text] [Related]
17. Insulin lispro and regular insulin in pregnancy.
Bhattacharyya A; Brown S; Hughes S; Vice PA
QJM; 2001 May; 94(5):255-60. PubMed ID: 11353099
[TBL] [Abstract][Full Text] [Related]
18. A comparison of insulin lispro and buffered regular human insulin administered via continuous subcutaneous insulin infusion pump.
Raskin P; Holcombe JH; Tamborlane WV; Malone JI; Strowig S; Ahern JA; Lavent F
J Diabetes Complications; 2001; 15(6):295-300. PubMed ID: 11711322
[TBL] [Abstract][Full Text] [Related]
19. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
[TBL] [Abstract][Full Text] [Related]
20. Insulin lispro in the treatment of patients with type 2 diabetes mellitus after oral agent failure.
Bastyr EJ; Johnson ME; Trautmann ME; Anderson JH; Vignati L
Clin Ther; 1999 Oct; 21(10):1703-14. PubMed ID: 10566566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
